These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 12824864

  • 1. Increased plasma concentrations of osteoprotegerin in type 2 diabetic patients with microvascular complications.
    Knudsen ST, Foss CH, Poulsen PL, Andersen NH, Mogensen CE, Rasmussen LM.
    Eur J Endocrinol; 2003 Jul; 149(1):39-42. PubMed ID: 12824864
    [Abstract] [Full Text] [Related]

  • 2. Plasma osteoprotegerin concentrations in type 1 diabetic patients with albuminuria.
    Elsamahy MH, Elhenawy YI, Nawar MM.
    J Diabetes Complications; 2015 Jul; 29(4):563-7. PubMed ID: 25744546
    [Abstract] [Full Text] [Related]

  • 3. Alteration of plasma concentrations of OPG before and after levothyroxine replacement therapy in hypothyroid patients.
    Guang-Da X, Hui-Ling S, Zhi-Song C, Lin-Shuang Z.
    J Endocrinol Invest; 2005 Dec; 28(11):965-72. PubMed ID: 16483173
    [Abstract] [Full Text] [Related]

  • 4. Plasma osteoprotegerin levels are associated with glycaemic status, systolic blood pressure, kidney function and cardiovascular morbidity in type 1 diabetic patients.
    Rasmussen LM, Tarnow L, Hansen TK, Parving HH, Flyvbjerg A.
    Eur J Endocrinol; 2006 Jan; 154(1):75-81. PubMed ID: 16381994
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Association between plasma osteoprotegerin concentrations and urinary albumin excretion in Type 2 diabetes.
    Xiang GD, Pu JH, Zhao LS, Sun HL, Hou J, Yue L.
    Diabet Med; 2009 Apr; 26(4):397-403. PubMed ID: 19388970
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Osteoprotegerin is independently associated with metabolic syndrome and microvascular complications in type 2 diabetes mellitus.
    Tavintharan S, Pek LT, Liu JJ, Ng XW, Yeoh LY, Su Chi L, Chee Fang S.
    Diab Vasc Dis Res; 2014 Sep; 11(5):359-62. PubMed ID: 25005034
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Increased plasma osteoprotegerin concentrations in Type 1 diabetes with albuminuria.
    Wang ST, Xu JM, Wang M, Chen FL, Ding G.
    Clin Nephrol; 2013 Mar; 79(3):192-8. PubMed ID: 23073066
    [Abstract] [Full Text] [Related]

  • 11. Arterial osteoprotegerin: increased amounts in diabetes and modifiable synthesis from vascular smooth muscle cells by insulin and TNF-alpha.
    Olesen P, Ledet T, Rasmussen LM.
    Diabetologia; 2005 Mar; 48(3):561-8. PubMed ID: 15700136
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Elevated serum osteoprotegerin levels are associated with vascular endothelial dysfunction in type 2 diabetes.
    Shin JY, Shin YG, Chung CH.
    Diabetes Care; 2006 Jul; 29(7):1664-6. PubMed ID: 16801598
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.